This week, health officials confirmed a new polio case in Jacobadad, a district in Sindh, Pakistan. This is the second polio case detected in the area this year– the other being in Karachi– bringing the total number of cases in Pakistan to six. Authorities say that, despite receiving the vaccine seven times, 18-month-old Noor Fatima still contracted the virus, adding that the virus can still occur in children who have low immunity, even after receiving the vaccine. The National Institutes of Health (NIH) in Islamabad confirmed the case after reviewing the child’s lab results. The city of Karachi says it will be holding a three-day eradication drive beginning on March 14, and will target 2.2 million children to be vaccinated.
Members of a Rotary Club in North Carolina are banding together to raise money for polio awareness by swimming laps as part of a fundraiser this weekend. The three-hour event, which will be held February 21 at the West Cabarrus YMCA pool in Concord, North Carolina, is part of Rotary International’s End Polio Nowinitiative, whose mission is to raise awareness of the disease and stop it in its tracks.
Rotary International has been an active participant in the fight to end polio since 1979, when it began vaccinating children in the Philippines. In the decades since, the organization has helped immunize approximately 2.5 billion children around the world across 122 countries. The swimming fundraiser is just one of the non-profit’s latest initiatives. For every dollar that’s raised at the event, the Bill & Melinda Gates Foundationwill double it.
A student has been granted bail by a court in Kashmir after he was accused of spreading a false rumor about deaths due to the polio vaccine. A prosecuting officer pleaded that the student, Irshad Ahmad, should not be given bail and that the offense should be punishable by either death or life imprisonment. After hearing the case, a judge concluded that the police failed to complete their investigation within the required two weeks, and told the accused not to leave the territory of Kashmir while out on bail.
Ahmad posted the rumor on his Facebook page on January 17, when thousands of parents were taking their children to clinics to receive oral polio immunizations. The accused wrote that “reports coming [in] that [the] polio vaccine used today was expired or toxic, huge number of children got fever, [and] even some death rumors circulating around.” After hearing the rumor, hundreds of frantic parents flooded the city’s healthcare centers seeking answers.
In a push toward eradicating polio in Pakistan for good, more than 100,000 healthcare workers descended on the Middle Eastern country earlier this week to help administer polio vaccinations. Pakistan is currently one of only two countries in the world where polio cases still exist, the other being Afghanistan, and it accounts for more than 70 percent of the world’s current cases of the debilitating illness. With the opening of the new immunization clinics, workers are striving to vaccinate every child in the country by May.
Efforts to halt the spread of polio in Pakistan have been an uphill battle and workers have been on the receiving end of numerous death threats by militants. Most recently, a suicide bomber killed at least 15 people outside of an immunization clinic in the city of Quetta earlier this year. However, workers are saying that through community outreach and education that their presence is becoming more accepted by the locals, and that they will continue administering the vaccine.
Starting in April 2016, 155 countries around the world have agreed to switch from one polio vaccine to another in what is being called the Global Polio Eradication Initiative (GPEI). Currently these countries use the oral trivalent polio vaccine (OPV), which protects against three types of the virus, but they will be transitioning over to the bivalent version, which blocks two types of polio. Currently the wild form of type 2 of the virus has been eradicated, but there are fears that the live, oral vaccine could mutate and cause reinfection, and switching to the bivalent version could help mitigate this risk.
Although the likelihood of this is exceedingly rare—according to the World Health Organization (WHO), billions of doses of the OPV have been administered between 2000 and 2015 and have resulted in fewer than 760 cases of the vaccine-derived poliovirus—this initiative will help lessen the risk. If successful, the switch will be “one of the most ambitious global synchronized projects in the history of vaccines,” according to the GPEI.
Earlier this month Bill Gates, founder of Microsoft and the Bill and Melinda Gates Foundation, traveled to Africa to meet with Aliko Dangote, Africa’s wealthiest man, alongside the governors of four of the continent’s northern states to discuss a new campaign that would help eradicate polio. Gates, along with many of Africa’s leaders, signed an MOU (Memorandum of Understanding), and are now set to raise childhood vaccination coverage to 80 percent by 2018 in the states of Borno, Yobe, Sokoto, and Kaduna.
In recent years, Africa has taken steps to end the spread of polio, but there is still much work to be done. Mario Mandara of the Gates Foundation says that vaccination rates in some of Africa’s northern states are as low as 30 percent. However, there hasn’t been a new case of wild polio reported in Africa since July 24, 2015 (Nigeria). If the UN World Health Organization (WHO) African Region goes two more years without a new case, the Africa Regional Certification Commission could declare Africa polio free.
On October 22, 2015, Kevin Kimberlin, chairman of Spencer Trask & Co., and Dr. Charlotte DeCroes Jacobs, author of the biography, “Jonas Salk: A Life,” joined together to celebrate the work of the late Jonas Salk, a visionary who discovered and developed the first successful vaccination for polio. It was a filled theater of enthusiastic supporters at the Grand Hyatt in Old Greenwich, CT.
At its peak in the 1940s and ’50s, polio paralyzed or killed more than half a million people worldwide each year. Since the introduction of Salk’s vaccine, cases of the crippling disease fell from 35,000 in 1953 to 5,300 in 1957 in the United States. By 2015, polio remained endemic in only two countries: Pakistan and Afghanistan.
In his speech, Kimberlin said that the World Health Organization (WHO), which has teamed up with UNICEF, Rotary International, the Center for Disease Control (CDC), and the Bill & Melinda Gates Foundation, recently announced that, “by the end of 2015, virtually every nation in the world, 195 out of 196 countries, have agreed to use or are already using the Salk vaccine to completely eradicate polio.” He added that, “the elimination of polio has recently been called the largest ever international mobilization in times of peace.”
He shared with the audience that “As a friend and the co-founder of a company called the Response Corporation, I got to know Jonas very well and I was tremendously inspired every moment of every day that I spent with him.”
Turning the stage over to Jacobs, she added that “Jonas Salk made some of the most major contributions to medicine, not only with his polio vaccine, but with his co-developed, first effective influenza vaccine and was working on an AIDS vaccine when he died.”
Jacobs shared her personal experience, that in 1954, the March of Dimes had selected her hometown of Kingsport, Tennessee, as one of the test sites for the polio vaccine, and she was one of the first children to receive and was dubbed a “polio pioneer.” A year later, it was announced that the vaccine proved effective and that polio could be prevented, making Salk one of the greatest heroes of our time.
For her book, Jacobs conducted more than 100 interviews with Salk’s family members, friends, classmates, and scientists to get an “intimate portrait” of the visionary. She learned that in 1986, a 33-year-old entrepreneur named Kevin Kimberlin gave him a call and told him that he wanted to work with him on the AIDS epidemic. At first Salk was wary, but eventually a friendship blossomed and together they founded the Immune Response Corporation. “I think Kevin shares the key characteristics that made Jonas so successful, and that is idealism, passion, and tenacity,” Jacobs said.
Although we’re closer than ever to eradicating polio for good, there are still challenges ahead…but the fight isn’t over yet.
As part of the Government of Afghanistan’s ongoing efforts to eradicate polio and strengthen routine immunization, H.E Dr. Ferozuddin Feroz, Minister of Public Health of Afghanistan, today formally introduced the Inactivated Polio Vaccine (IPV) into the schedule of routine vaccinations programme for all children under the age of one.
Today’s introduction of IPV into the routine immunisation schedule in Afghanistan is part of a worldwide roll-out of the vaccine across 126 countries – the largest and fastest globally coordinated vaccine introduction project in history. It is funded as part of the budget of the Global Polio Eradication Initiative (GPEI), and support is channelled through Gavi, the Vaccine Alliance, WHO and UNICEF.
The Bill & Melinda Gates Foundation, Norway, and the United Kingdom are generously supporting the introduction of IPV in routine immunization schedules in 72 Gavi-supported countries, while Canada is supporting its introduction in other lower-middle income countries. The top ten government donors to GPEI include the USA, the UK, Japan, Germany, Canada, the Netherlands, Norway and Australia.
The Salk vaccine eradicates polio — forever. Come celebrate World Polio Day and the esteemed Salk biographer, Charlotte DeCroes Jacobs, M.D. at the Hyatt Regency in Greenwich, CT, 1800 East Putnam Avenue.
Because of HEROs like Jonas Salk we are on the cusp of the eradication of Polio. Hear the uplifting success story of Dr. Salk’s humanitarian efforts told by Jonas Salk biographer, Charlotte DeCroes Jacobs. Kevin Kimberlin, Spencer Trask Chairman, business partner of Jonas Salk explaining how Salk’s work has contributed to the next potential health revolution – personalized vaccines. We dare you to leave unchanged.